Company Profiles

driven by the PitchBook Platform

Genotype Diagnostics

Genotype Diagnostics
PRIVATE STATUS
Buyout/LBO LATEST DEAL TYPE
1 INVESTORS
Description

Provider of molecular analysis technology designed to recognize variations in one's DNA that correlates with abnormal cell functions. The company's molecular analysis technology's approach is similar to the reasoning behind popular voice, text and image-recognition apps where context is important for arriving at the right answer, enabling healthcare consumers understand their own genetic blueprint.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
244 Fifth Avenue
Number 2332
New York, NY 10001
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Genotype Diagnostics’s full profile, request a free trial.

Genotype Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Buyout/LBO 01-Jan-2011 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Genotype Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Paliwoda Group Venture Capital Majority 000 0000 000000 0

You’re viewing 1 of 1 investors.